ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Potential Roles of Selectins in Periodontal Diseases and Associated Systemic Diseases: Could They Be Targets for Immunotherapy?

Zhong, Mei; Huang, Jiangyong; Wu, Zhe; Chan, Kok-Gan*; Wang, Lijing; Li, Jiang; Lee, Learn-Han*; Law, Jodi Woan-Fei广东药学院; 广州医学院; 江苏大学
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES2022-11DOI: 10.3390/ijms232214280
3被引10阅读
引用收藏
分享

摘要

Periodontal diseases are predisposing factors to the development of many systemic disorders, which is often initiated via leukocyte infiltration and vascular inflammation. These diseases could significantly affect human health and quality of life. Hence, it is vital to explore effective therapies to prevent disease progression. Periodontitis, which is characterized by gingival bleeding, disruption of the gingival capillary's integrity, and irreversible destruction of the periodontal supporting bone, appears to be caused by overexpression of selectins in periodontal tissues. Selectins (P-, L-, and E-selectins) are vital members of adhesion molecules regulating inflammatory and immune responses. They are mainly located in platelets, leukocytes, and endothelial cells. Furthermore, selectins are involved in the immunopathogenesis of vascular inflammatory diseases, such as cardiovascular disease, diabetes, cancers, and so on, by mediating leukocyte recruitment, platelet activation, and alteration of endothelial barrier permeability. Therefore, selectins could be new immunotherapeutic targets for periodontal disorders and their associated systemic diseases since they play a crucial role in immune regulation and endothelium dysfunction. However, the research on selectins and their association with periodontal and systemic diseases remains limited. This review aims to discuss the critical roles of selectins in periodontitis and associated systemic disorders and highlights the potential of selectins as therapeutic targets.

学科与关键词

关键词
periodontal diseaseselectinsystemic diseasediabetescardiovascular diseasehost immune responsetherapeutic target
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
发表日期
2022-11
卷期
第 23 卷, 第 22 期
页码
14280
DOI
10.3390/ijms232214280
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
University of Malaya [RMF12522021]; Jeffrey Cheah School of Medicine and Health Sciences Strategic Grant 2022 [STG-000108]

作者

  • Z

    Zhong, Mei (第一作者)

    guangzhou med univ

  • H

    Huang, Jiangyong

    guangzhou med univ

查看全部 8 位作者收起作者
  • W

    Wu, Zhe

    guangzhou med univ

  • C

    Chan, Kok-Gan (通讯)

    jiangsu univ

  • W

    Wang, Lijing

    guangdong pharmaceut univ · guangzhou med univ

  • L

    Li, Jiang

    guangzhou med univ

  • L

    Lee, Learn-Han (通讯)

  • L

    Law, Jodi Woan-Fei

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417